Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

Long-Acting Injectable HIV Regimen Effective in Maintaining Viral Suppression

March 14, 2019

ViiV Healthcare announced positive 48-week data from the phase 3 studies evaluating a long-acting injectable formulation of cabotegravir + rilpivirine in patients with HIV.

HIV/AIDS

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

Da Hee Han, PharmD

November 29, 2018

The FDA has approved Temixys tablets for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients weighing ≥35kg.

HIV/AIDS

Intravenous Drug Approved for Multidrug-Resistant HIV Infection

Da Hee Han, PharmD

March 7, 2018

The FDA has approved Trogarzo for the treatment of adults with HIV whose infections are multidrug-resistant.

Next post in HIV/AIDS

Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

Long-Acting Injectable HIV Regimen Effective in Maintaining Viral Suppression

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

Intravenous Drug Approved for Multidrug-Resistant HIV Infection

Efficacy of Immediate Oral Etoposide for Mild to Moderate AIDS-Related Kaposi Sarcoma